Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QMS Medical Allied ServicesNSE:QMSMEDI +2.24%74 Return-on-Tangible-Equity is 11.60% as of Mar. 2026, which is 44% below its 10-year median of 20.56. GuruFocus rates NSE:QMSMEDI with a GF Score™ of 74/100 and a GF Value™ of ₹120.73 (Fairly Valued). The stock has 7 warning signs investors should review. Among 758 Medical Devices & Instruments companies, QMS Medical Allied Services ranks better than 79.42% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. QMS Medical Allied Services's annualized net income for the quarter that ended in Mar. 2026 was ₹81 Mil. QMS Medical Allied Services's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹696 Mil. Therefore, QMS Medical Allied Services's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 11.60%.
The historical rank and industry rank for QMS Medical Allied Services's Return-on-Tangible-Equity or its related term are showing as below:
NSE:QMSMEDI'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 12.41 Med: 20.56 Max: 74.11
Current: 16.91
During the past 7 years, QMS Medical Allied Services's highest Return-on-Tangible-Equity was 74.11%. The lowest was 12.41%. And the median was 20.56%.
NSE:QMSMEDI's Return-on-Tangible-Equity is ranked better than 79.42% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.08
vs NSE:QMSMEDI: 16.91
QMS Medical Allied Services (NSE:QMSMEDI) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
QMS Medical Allied Services Return-on-Tangible-Equity Related Terms
QMS Medical Allied Services Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QMS Medical Allied Services Return-on-Tangible-Equity Chart
NSE:QMSMEDI vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QMS Medical Allied Services Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where QMS Medical Allied Services's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 11.60% mean?
QMS Medical Allied Services (NSE:QMSMEDI) has a Return-on-Tangible-Equity of 11.60% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on QMS Medical Allied Services and its competitors. This is 44% below median its historical median of 20.56. Over the past decade, QMS Medical Allied Services' Return-on-Tangible-Equity has ranged from 12.41 to 74.11. According to the industry distribution chart, QMS Medical Allied Services ranks #156 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 20.6%.
Is QMS Medical Allied Services' Return-on-Tangible-Equity too high?
QMS Medical Allied Services' current Return-on-Tangible-Equity of 11.60% is 44% below median its 10-year median of 20.56. Over the past 10 years, this metric has ranged from a low of 12.41 to a high of 74.11. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.08. QMS Medical Allied Services' value of 11.60% is 184.3% above this industry median. Based on the distribution chart, QMS Medical Allied Services ranks #156 out of 758 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, QMS Medical Allied Services has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does QMS Medical Allied Services' Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, QMS Medical Allied Services ranks #156 out of 758 companies for Return-on-Tangible-Equity. This places QMS Medical Allied Services in the top 21% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.08. QMS Medical Allied Services' value of 11.60% is 184.3% above this benchmark. Historically, QMS Medical Allied Services' own Return-on-Tangible-Equity has ranged from 12.41 to 74.11 over the past decade. While the company's 10-year median is 20.56 vs. the industry median of 4.08, QMS Medical Allied Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QMS Medical Allied Services's current Return-on-Tangible-Equity of 11.60% is 184.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on QMS Medical Allied Services and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QMS Medical Allied Services's current Return-on-Tangible-Equity is 11.60%, which is 44% below median its own 10-year median of 20.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QMS Medical Allied Services stock overvalued right now?
Based on GuruFocus' analysis, QMS Medical Allied Services (NSE:QMSMEDI) is currently considered Fairly Valued. The stock's GF Value™ is ₹120.73, compared to a current price of ₹110.60 — trading 8.4% below its estimated fair value. The current Return-on-Tangible-Equity is 11.60%, which is 44% below median its 10-year median of 20.56 and 184.3% above the Medical Devices & Instruments industry median of 4.08. QMS Medical Allied Services' overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For QMS Medical Allied Services (NSE:QMSMEDI), the current Return-on-Tangible-Equity is 11.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?
Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be undervalued.
The current stock price of ₹110.60 is trading 8.4% below its estimated GF Value™ of ₹120.73.
GuruFocus considers QMS Medical Allied Services to be Fairly Valued.
Key valuation signals for NSE:QMSMEDI:
Return-on-Tangible-Equity: 11.60% (44% below median its 10-year median of 20.56)
GF Value™: ₹120.73 vs. price of ₹110.60 (8.4% below fair value)
Industry Position: 184.3% above the Medical Devices & Instruments median (#156 of 758)
No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
74GF Score
Get the complete analysis for NSE:QMSMEDI
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QMSMEDI has been successfully added to your 
